THE AMERICAS AFRICA ASIA

| HOME | TABLE OF CONTENTS | ACKNOWLEDGEMENTS | ACRONYMS AND ABBREVIATIONS | USERS’ GUIDE AND EXPLANATORY NOTES | FOREWORD | INTRODUCTION | I: GLOBAL MALARIA SITUATION | II: MALARIA CONTROL, BY REGION | III: GLOBAL FINANCING | IV: IMPROVING RBM MONITORING AND EVALUATION | REFERENCES |
RBM PartnershipUNICEFWHO/RBM Department

USERS' GUIDE AND EXPLANATORY NOTES

1. Country data by region

Regional and subregional classifications of countries and territories are presented in Annex 2. The information from countries and territories considered to be malariaendemic is presented from three broad global regions: Africa, Asia and the Americas, which are further divided into subregions. Groupings are based on geographical proximity and, secondarily, on existing WHO regional groupings.

2. WHO standard definitions

All WHO standard malaria case definitions and other related definitions are presented in Annex 5.

3. Where space is limited, the following abbreviations have been used:

  • in country or region names:
  • C. AmericaCentral America
    C. AsiaCentral Asia
    CARCentral African Republic
    DPR KoreaDemocratic People’s Republic of Korea
    Dr CongoDemocratic Republic of the Congo
    Eastern Medit.Eastern Mediterranean
    IranIslamic Republic of Iran
    Lao PDRLao People’s Democratic Republic
    Sao Tome & Prin.Sao Tome and Principe
    SE AsiaSouth-East Asia
    UAEUnited Arab Emirates
    URTanzania United Republic of Tanzania
  • in drug names:
  • AQamodiaquine
    AQ+SPamodiaquine+sulfadoxine–pyrimethamine
    ATMartemether
    ATM+CQartemether+chloroquine
    ATM-LUMartemether–lumefantrine
    ASUartesunate
    ASU-combartesunate combinations
    ASU+AQartesunate+amodiaquine
    ASU+CQartesunate+chloroquine
    ASU+MQartesunate+mefloquine
    ASU+SPartesunate+sulfadoxine–pyrimethamine
    CQchloroquine
    CQ+SPchloroquine+sulfadoxine–pyrimethamine
    Cclindamycin
    DHAdihydroartemisinin
    Ddoxycycline
    MQmefloquine
    MQ+SPmefloquine+sulfadoxine–pyrimethamine
    PPQpiperaquine
    PQprimaquine
    PYRpyronaridine
    Qquinine
    Q+SPquinine+sulfadoxine–pyrimethamine
    SPsulfadoxine–pyrimethamine
    Ttetracycline
    TMPtrimethoprim
  • in tables and graphics:
  • ANCantenatal clinic
    CCMCountry Coordinating Mechanism
    CMSCommercial Market Strategies
    dday
    GTZDeutsche Gesellschaft für Technische Zusammenarbeit GmbH
    HDSHema Diagnostic Systems
    HHhousehold
    MoFMinistry of Finance
    NAnot applicable
    NRnot reported
    NSONational Statistical Office
    PfP. falciparum
    Pop.population
    PvP. vivax
    PWpregnant women
    RDTrapid diagnostic test
    Reg. Org.Regional Organization
    trim.trimester(s)
    U5 or under-5(children) under 5 years of age